Global Tech Reporter
SEE OTHER BRANDS

Get your daily news on science and technology

Global Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.

Press releases published on July 18, 2025

FOXO TECHNOLOGIES INC. ANNOUNCES INTENTION TO SPIN OFF EPIGENETICS SUBSIDIARY

FOXO TECHNOLOGIES INC. ANNOUNCES INTENTION TO SPIN OFF EPIGENETICS SUBSIDIARY

WEST PALM BEACH, FLORIDA, July 18, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), today announced that its Board of Directors has approved pursuing the spin-off of its FOXO Labs, Inc. subsidiary that is …

Ocugen, Inc. Announces First Patient Dosed in Phase 2/3 GARDian3 Pivotal Confirmatory Trial for OCU410ST—Novel Modifier Gene Therapy Candidate for Stargardt Disease

Ocugen, Inc. Announces First Patient Dosed in Phase 2/3 GARDian3 Pivotal Confirmatory Trial for OCU410ST—Novel Modifier Gene Therapy Candidate for Stargardt Disease

MALVERN, Pa., July 18, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the first patient has been dosed in its Phase 2/3 GARDian3 …

Thérapeutique Knight annonce le dépôt d’une nouvelle soumission réglementaire pour CREXONT® (carbidopa et lévodopa) au Canada en capsules à libération prolongée

Thérapeutique Knight annonce le dépôt d’une nouvelle soumission réglementaire pour CREXONT® (carbidopa et lévodopa) au Canada en capsules à libération prolongée

MONTRÉAL, 18 juill. 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), a annoncé aujourd’hui que la soumission de drogue nouvelle (SDN) pour CREXONT® a été …

Knight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada

Knight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada

MONTREAL, July 18, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that Knight's New Drug Submission (NDS) for CREXONT® has been accepted for review by …

KFSHRC führt weltweit erste robotergestützte BiVAD-Implantation durch

KFSHRC führt weltweit erste robotergestützte BiVAD-Implantation durch

RIAD, Saudi-Arabien, July 18, 2025 (GLOBE NEWSWIRE) -- Im King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riad wurde bei einem Patienten mit fortgeschrittener Herzinsuffizienz erfolgreich die weltweit erste Implantation von zwei künstlichen …

Le KFSHRC réalise la première implantation au monde d’un dispositif BiVAD assisté par robot

Le KFSHRC réalise la première implantation au monde d’un dispositif BiVAD assisté par robot

RIYAD, Arabie saoudite, 18 juill. 2025 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital …

Aurora Mobile's JPush Empowers Beijing Hyundai Auto Finance to Build an Efficient and Secure Mobile Financial Service Platform

Aurora Mobile's JPush Empowers Beijing Hyundai Auto Finance to Build an Efficient and Secure Mobile Financial Service Platform

SHENZHEN, China, July 18, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced that its push notification …

UPDATE -- KOORUI G Series Combo – G2411P and G2741L – Makes a Strong Prime Day Debut with Budget Gaming Appeal

UPDATE -- KOORUI G Series Combo – G2411P and G2741L – Makes a Strong Prime Day Debut with Budget Gaming Appeal

NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- KOORUI, a rising global force in smart hardware and consumer electronics, unveiled its latest G Series gaming monitors – G2411P and G2741L – ahead of Prime Day. Designed with precision, speed, and compatibility …

ImCheck’s ICT01 Receives FDA Orphan Drug Designation  for Treatment of Acute Myeloid Leukemia

ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia

ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials Marseille, France, July 18, 2025, …

Bitget Lists Yooldo Games (ESPORTS) for Spot Trading

Bitget Lists Yooldo Games (ESPORTS) for Spot Trading

Seychelles, Victoria, July 18th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of Yooldo Games (ESPORTS) in the Innovation and GameFi Zone, adding it to spot trading. Yooldo is a multi-chain Web3 …

Mint Miner Launches Cloud Mining™: Free Bonuses and Guaranteed Crypto Returns for Everyone

Mint Miner Launches Cloud Mining™: Free Bonuses and Guaranteed Crypto Returns for Everyone

New York City, NY, July 18, 2025 (GLOBE NEWSWIRE) -- Mint Miner, a leading global digital asset infrastructure provider, today officially launched its next-generation Cloud Mining™ platform, making it easy to earn cryptocurrencies without technical …

SoulGen Launches Revolutionary Image to Video AI Platform with Industry-Leading Character Consistency

SoulGen Launches Revolutionary Image to Video AI Platform with Industry-Leading Character Consistency

HONG KONG, July 18, 2025 (GLOBE NEWSWIRE) -- SoulGen, a leading artificial intelligence company specializing in image to video AI technology, today announced the commercial launch of its proprietary platform that transforms static images into dynamic, …

Hivello’s HVLO Token Now Available in Binance Mobile App

Hivello’s HVLO Token Now Available in Binance Mobile App

LONDON and AMSTERDAM, July 18, 2025 (GLOBE NEWSWIRE) -- Hivello, a DePIN aggregator that enables users to earn by monetizing idle (computing) resources across multiple DePINs (Decentralized Physical Infrastructure Networks), announces a significant …

Norsk Hydro: Frivillig oppsigelse av kraftavtale med Cloud Snurran AB

Norsk Hydro: Frivillig oppsigelse av kraftavtale med Cloud Snurran AB

Hydro har inngått et forlik angående en langsiktig kraftkjøpsavtale (PPA) med Cloud Snurran AB. I forliket har Hydro rett til en kompensasjon på opptil 90 millioner euro for sin frivillige oppsigelse av avtalen.  Hydro Energi AS inngikk i 2018 en PPA med …

Norsk Hydro: Voluntary termination of power purchase agreement with Cloud Snurran AB

Norsk Hydro: Voluntary termination of power purchase agreement with Cloud Snurran AB

Hydro has agreed to a settlement for the long-term power purchase agreement (PPA) with Cloud Snurran AB. In the settlement, Hydro is entitled to compensation of up to EUR 90 million for its voluntary termination of the PPA.  Hydro Energi AS signed a long- …

Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research & Development

Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research & Development

Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research …

Strong tailwind for Telenor in Q2

Strong tailwind for Telenor in Q2

(Fornebu, Norway – 18 July 2025) Telenor Group delivers very strong results in the second quarter of 2025, triggering a raised EBITDA outlook for both the Nordics and Group. At the same time the company solidifies its position in the Nordic fibre market …

Sterk medvind for Telenor i andre kvartal

Sterk medvind for Telenor i andre kvartal

(Fornebu, 18. juli 2025) Telenor-konsernet leverer svært sterke resultater i andre kvartal og oppjusterer derfor EBITDA-utsiktene for både Norden og konsernet. Samtidig tar selskapet en solid posisjon i det nordiske fibermarkedet med en investering på …

Press Release: Sanofi completes acquisition of Blueprint Medicines

Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a promising pipeline, and …

Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines

Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines

Sanofi finalise l’acquisition de Blueprint Medicines Paris, le 18 juillet 2025. Sanofi annonce aujourd’hui la finalisation de l’acquisition de Blueprint Medicines Corporation (Blueprint). La nouvelle entreprise ajoute au portefeuille de Sanofi des …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service